MS unit7(2)Comprehensive Study Guide on Acid-Base Alkalosis and Shock Pathophysiology

Fundamentals of Alkalosis: Respiratory and Metabolic Derangements

  • Baseline Definition and Identification:

    • Alkalosis is defined by a systemic arterial blood pH>7.45pH > 7.45.
    • The primary initial parameter evaluated in any suspected acid-base disturbance is the systemic pHpH.

  • Respiratory Alkalosis:

    • Primary Etiological Driver: The underlying pathology resides within the respiratory system, characterized by an abnormal arterial partial pressure of carbon dioxide (PaCO2PaCO_2).
    • Diagnostic Laboratory Parameters:
      • pH>7.45pH > 7.45
      • PaCO2<32 mmHgPaCO_2 < 32\,\text{mmHg}
    • Pathophysiology: Carbon dioxide (CO2CO_2) functions as a physiological acid. In hyperdynamic respiratory states, rapid elimination of CO2CO_2 depletes systemic acid content, driving systemic pHpH into an alkalotic range.
    • Renal Compensation: When the respiratory system causes alkalosis, the renal system compensates by decreasing the retention and reabsorption of bicarbonate (HCO3−HCO_3^-). The kidneys excrete excess base to re-establish physiological equilibrium.
    • Precipitating Factors:
      • Hyperventilation secondary to severe anxiety or acute panic attacks.
      • Iatrogenic mechanical over-ventilation, particularly during manual resuscitation (CPR) involving rapid, continuous, high-volume bag-valve-mask ventilations that over-inflate the pulmonary parenchyma.
      • Thyroid disorders that increase basal metabolic demand and ventilatory drive.
    • Clinical Manifestations:
      • Neurological deterioration: Declining level of consciousness and impaired judgment.
      • Respiratory presentation: Markedly deep, rapid ventilations (tachypnea and hyperpnea).
      • Cardiovascular changes: Tachycardia paired with a decrease in systemic blood pressure.
      • Electrolyte shifts: Hypokalemia resulting from intracellular potassium-hydrogen ion exchanges.
    • Acute Intervention: Directing the individual to breathe into a paper bag. Re-inhaling exhaled air traps expired acidic CO2CO_2, forcing it back into the alveoli and circulation to neutralize the alkaline base.

  • Metabolic Alkalosis:

    • Primary Etiological Driver: The underlying defect originates within renal or gastrointestinal mechanisms, resulting in an excess of bicarbonate (HCO3−HCO_3^-).
    • Diagnostic Laboratory Parameters:
      • pH>7.45pH > 7.45
      • HCO3−>26 mEq/LHCO_3^- > 26\,\text{mEq/L}
    • Respiratory Compensation: The respiratory system compensates by conserving acid. Compensatory breathing shifts into a "low and slow" pattern—depressed respiratory rate and shallow depth—to retain acidic CO2CO_2 and offset excess bicarbonate.
    • Precipitating Factors:
      • Excessive ingestion of commercial antacids.
      • Oral consumption of sodium bicarbonate (baking soda mixed in water) as a home remedy for gastric discomfort.
      • Diuretic therapy resulting in contraction alkalosis.
      • Direct loss of hydrochloric acid through severe vomiting or continuous gastrointestinal nasogastric suctioning.
    • Clinical Manifestations:
      • Altered level of consciousness.
      • Gastrointestinal disturbances including nausea, vomiting, and diarrhea.
      • Neuromuscular irritability presenting as physical tremors.

  • General Medical and Nursing Interventions for Alkalosis:

    • Definitive management requires identifying and treating the underlying root pathology.
    • Severe renal dysfunction requires artificial filtration, such as hemodialysis.
    • Respiratory regulation may require non-invasive positive pressure support (CPAP or BiPAP).
    • Pharmacological management for hyperventilation induced by acute anxiety includes anxiolytics or sedating antihistamines (e.g., diphenhydramine).
    • Diagnostic clinical learning tools include the ROME mnemonic (Respiratory Opposite, Metabolic Equal) and the Tic-Tac-Toe interpretation method.

Systemic Pathophysiology and Compensatory Mechanisms of Shock

  • Core Pathophysiological Definition: Shock represents a state of cardiovascular collapse characterized by inadequate systemic blood pressure and impaired tissue perfusion, resulting in cellular hypoxia, failure of aerobic metabolism, and the toxic accumulation of metabolic waste products.

  • Triad of Perfusion Maintenance: Adequate cellular perfusion relies strictly on three physiological components:

    • Adequate circulating intravascular blood volume (absence of hypovolemia).
    • An effective, mechanically functional cardiac muscular pump.
    • Appropriate vascular smooth muscle tone (analogous to the elastic recoil of an intact rubber band versus a loose, overstretched band).

  • Sympathetic Nervous System (SNS) Activation:

    • Often recognized as the "fight-or-flight" autonomic response.
    • Triggers the massive adrenal release of catecholamines: epinephrine and norepinephrine.
    • Hemodynamic consequences: Significant increases in heart rate, cardiac contractility, total cardiac output, systemic blood pressure, and respiratory rate.
    • Selective peripheral vasoconstriction shunts circulating blood flow away from non-vital tissues to supply vital organs (heart and brain).
    • Metabolic consequences: Hepatic glycogenolysis drives a rapid rise in blood glucose levels to supply cellular fuel during critical stress.

  • Renin-Angiotensin-Aldosterone System (RAAS) Stimulation:

    • Hypoperfusion sensed by the renal apparatus activates the RAAS cascade.
    • Stimulates systemic arterial vasoconstriction.
    • Prompts renal tubular retention of sodium and water to expand intravascular circulating volume and support blood pressure.

  • Sequential Stages of Shock:

    • Stage 1: Preshock (Compensatory Shock): Compensatory neurohormonal mechanisms (SNS and RAAS) actively engage to preserve perfusion pressure; subtle deviations in vital signs emerge.
    • Stage 2: Progressive Shock: Compensatory mechanisms become overwhelmed and begin to fail; tissue hypoperfusion deepens and metabolic imbalances accelerate.
    • Stage 3: End-Organ Dysfunction (Irreversible Shock): Cellular oxygen starvation triggers irreversible tissue necrosis and widespread organ failure.

Major Complications and Systemic Sequelae of Shock

  • End-Organ System Pathologies:

    • Pulmonary System: Development of acute respiratory failure and Acute Respiratory Distress Syndrome (ARDS).
    • Renal System: Severe hypoperfusion induces renal insufficiency, progressing from acute kidney injury (AKI) to chronic, irreversible renal failure.
    • Cardiovascular System: Induces lethal cardiac arrhythmias, myocardial ischemia, and myocardial infarction.
    • Hepatic System: Impairs synthesis of plasma proteins and clotting factors, elevates serum liver enzymes, and leads to neurotoxic systemic ammonia buildup.
    • Immune System: Severe metabolic exhaustion collapses host defense mechanisms, leaving the body unprotected against secondary opportunistic infections.
    • Gastrointestinal System: Hypoperfusion causes mucosal ischemia and breakdown, systemic absorption of enteric bacterial endotoxins, acute pancreatitis, and paralytic ileus.
    • Central Nervous System: Critical cerebral hypoperfusion results in permanent hypoxic-ischemic brain damage and neuronal necrosis.

  • Acute Respiratory Distress Syndrome (ARDS):

    • High incidence observed during septic shock.
    • Pathophysiological changes include non-cardiogenic pulmonary edema and widespread pulmonary parenchymal fibrosis.
    • Fibrotic structural changes in alveolar lung tissue are permanent and non-reversible.
    • Clinical management requires invasive mechanical ventilation and eradication of the causative infectious etiology.

  • Disseminated Intravascular Coagulation (DIC):

    • Characterized by widespread microvascular clotting throughout systemic capillary beds, which completely exhausts available clotting factors and platelets.
    • The rapid consumption of clotting factors precipitates catastrophic, uncontrolled systemic hemorrhage.
    • Clinical management focus: Controlling hemorrhage is more challenging than treating thrombosis.
    • Procedural safeguards: Avoid invasive procedures likely to induce bleeding; apply sustained, prolonged direct manual pressure following required punctures (IV access, IM injections).
    • Therapeutics: Initial controlled administration of anticoagulants (heparin) to interrupt active microvascular clotting cascades, followed by the infusion of blood products, specifically Fresh Frozen Plasma (FFP) to replenish concentrated clotting factors.

  • Multiple Organ Dysfunction Syndrome (MODS):

    • Defined as the simultaneous or sequential progressive failure of multiple vital organ systems resulting from prolonged cellular hypoxia.
    • Represents the primary cause of mortality in patients suffering from shock.

Hypovolemic Shock: Etiology and Clinical Protocol

  • Underlying Pathophysiology: Shock triggered by severe deficit in circulating intravascular fluid volume.

  • Etiological Factors:

    • Internal or external massive hemorrhage (e.g., intraoperative blood loss, traumatic vascular laceration).
    • Severe gastrointestinal fluid losses secondary to intractable vomiting and diarrhea.
    • Extensive thermal burn injuries: Systemic intravascular fluid shifts out of the vascular tree into damaged tissues to fight local infection and cool burned tissue.
    • Third-spacing: Fluid shifting from the intravascular space into interstitial cavities.
    • Severe sepsis and traumatic injury.

  • Clinical Presentation:

    • Cardiovascular: Marked sinus tachycardia, tachypnea, and severe arterial hypotension.
    • Integumentary: Marked pallor, peripheral cyanosis, and flat, collapsed peripheral veins that complicate peripheral IV cannulation.
    • Renal: Oliguria progressing to absolute anuria due to profound renal hypoperfusion and volume conservation.
    • Neurological: Altered mental status secondary to cerebral ischemia.

  • Emergency Interventions and Nursing Care:

    • Hemorrhage Control: Immediate application of firm, direct manual pressure to active external bleeding sites; careful monitoring of post-operative surgical dressings and internal drainage systems for hidden blood loss.
    • Urinary Catheterization: Prompt placement of an indwelling Foley catheter to continuously assess strict hourly urine output as an indicator of end-organ perfusion.
    • Oxygenation: Immediate initiation of high-flow supplemental oxygen therapy.
    • Patient Positioning: Placement into a modified Trendelenburg position (patient supine with the trunk flat and lower extremities elevated). Traditional Trendelenburg (entire bed tilted head down) is strictly avoided due to the adverse risk of increasing intracranial pressure.
    • Intravenous Access: Immediate placement of two large-bore IV access lines (one dedicated to concurrent crystalloid infusion and blood administration; the second dedicated to vasoactive medication infusions).
    • Volume Resuscitation: Rapid infusion of crystalloids (0.9%0.9\% Normal Saline) and urgent crossmatched or emergent blood products.
    • Vasopressor Therapy:
      • Pharmacological agents: Vasopressin, epinephrine, norepinephrine (Levophed).
      • Mechanism of action: Profound arterial vasoconstriction designed to elevate systemic vascular resistance and blood pressure (analogous to compressing the tip of a water hose to elevate exit pressure).
      • Adverse complications: Severe peripheral vasoconstriction leads to ischemic necrosis of the distal extremities (fingers and toes).
      • Medication Safety Note: Strict prevention of drug administration errors, highlighting an incident where an override led to a patient receiving an IV push of the vasopressor Levophed instead of the ordered antibiotic Levaquin, alongside the fatal error of transfusing blood products without filtered blood-administration tubing.
    • Surgical Evaluation: Preparation for exploratory surgery if hemorrhage cannot be stabilized medically.

Cardiogenic Shock: Pump Failure and Management

  • Pathophysiology: Primary mechanical or electrical failure of the cardiac muscular pump, rendering the heart incapable of generating sufficient cardiac output to sustain vital tissue perfusion.

  • Precipitating Conditions:

    • Myocardial infarction (post-MI structural necrosis).
    • Direct acute cardiac trauma.
    • Inflammatory cardiac diseases (endocarditis, myocarditis).
    • Malignant cardiac arrhythmias, predominantly of ventricular origin.
    • Acute or decompensated severe cardiac valvular disease.
    • End-stage congestive heart failure.

  • Clinical Manifestations:

    • Cardiopulmonary: Severe dyspnea, labored breathing, and profound systemic hypotension.
    • Integumentary and Renal: Marked pallor, cyanosis, and oliguria.
    • Vascular: Neck veins may present as either flat or engorged/distended depending on right ventricular loading.
    • Neurological: Cognitive impairment and altered mental status.
    • Hallmark Distinguishing Sign: Acute pulmonary edema presenting with pink, frothy sputum, indicating high-pressure retrograde fluid accumulation in the pulmonary bed from left ventricular failure.

  • Medical Interventions:

    • Diuretics: Administered to clear fluid overload and relieve alveolar congestion.
    • Nitrates (e.g., Nitroglycerin): Administered to induce peripheral and coronary vasodilation (expanding the vascular network from a two-lane highway to a four-lane highway), reducing cardiac preload and afterload to allow more efficient myocardial pumping.
    • Inotropes and Vasopressors: Cautiously titrated to augment cardiac contractility and maintain minimal acceptable mean arterial pressure.
    • Supplemental Oxygen: High-flow oxygen delivery.
    • Positioning: Upright, high-Fowler's position to reduce systemic venous return (preload) and lower intrathoracic pressure.

Distributive Shock Subtypes: Anaphylactic, Septic, and Neurogenic

  • General Definition: Shock characterized by widespread, abnormal vasodilation throughout the systemic circulation, leading to relative hypovolemia despite normal fluid volume.

  • Anaphylactic Shock:

    • Pathophysiological Trigger: Severe, systemic Type I hypersensitivity allergic reaction upon exposure to an offending antigen.
    • Airway and Pulmonary Hallmarks: Severe laryngeal edema, tracheal constriction, marked inspiratory and expiratory wheezing, and complete airway closure.
    • Clinical Presentation: Sudden cardiovascular collapse with hypotension, tachycardia, tachypnea, altered sensorium, diffuse urticaria (hives), and an acute sense of impending doom.
    • Therapeutic Management:
      • Immediate intramuscular or intravenous Epinephrine: Acts via beta-2 receptor stimulation to induce bronchodilation while simultaneously activating alpha-1 receptors to drive vasoconstriction, supporting systemic blood pressure.
      • Secondary pharmacotherapy: Antihistamines and systemic corticosteroids.
      • Airway preservation: Emergency surgical tracheostomy or cricothyroidotomy if laryngeal edema prevents endotracheal intubation.

  • Septic Shock:

    • Pathophysiological Trigger: Systemic inflammatory response to an invasive infectious pathogen (commonly endotoxin-producing Gram-negative bacteria) that originates as a localized process and spreads hematogenously (e.g., an ascending urinary tract infection progressing to cystitis, pyelonephritis, and lethal urosepsis).
    • Early (Warm) Phase:
      • Systemic hyperdynamic state with peripheral vasodilation.
      • Vital signs: Mild tachycardia (e.g., HR=102 bpmHR = 102\,\text{bpm}), tachypnea (e.g., RR=21–22 breaths/minRR = 21\text{--}22\,\text{breaths/min}), baseline or minimally altered blood pressure.
      • Physical exam: Warm, flushed skin, normal capillary refill, preserved urinary output, and variable temperature (hypothermic, normothermic, or febrile).
      • Clinical risk: The subtlety of early signs often fails to raise alarm during routine nursing assessments.
    • Late (Cold) Phase:
      • Cardiovascular collapse with severe arterial hypotension, worsening tachycardia, and tachypnea.
      • Physical exam: Sluggish, delayed capillary refill, cool and pale integument, hypothermia, marked oliguria, and profound altered mental status.
    • Diagnostic and Monitoring Protocols:
      • Obtain immediate blood cultures and sensitivity (C&S) prior to administering broad-spectrum intravenous antibiotic therapy.
      • Implementation of the Modified Early Warning System (MEWS): An automated, multi-parameter clinical algorithm (utilized across hospital networks, such as HCA facilities and Pinewood) that continuously evaluates subtle physiological trends (e.g., a baseline heart rate shifting from 82 bpm82\,\text{bpm} to an abnormal trend of 98 bpm98\,\text{bpm}, minor blood pressure dips, marginal shifts in white blood cell counts, and temperature trends).
      • MEWS Utility Example: A stabilized patient evaluated at 07:0007:00 generated an automated MEWS alert at 11:0011:00 from mild vital sign shifts, prompting a rapid response within 30 minutes30\,\text{minutes}, transfer to the intensive care unit in under 1 hour1\,\text{hour}, and progression to endotracheal mechanical ventilation by the following shift.

  • Neurogenic Shock:

    • Pathophysiological Trigger: Disruption of descending autonomic pathways following acute central nervous system pathology, spinal cord trauma, deep anesthesia, or hyperpyrexia.
    • Hemodynamic Presentation: Total loss of vascular sympathetic vasomotor tone, leading to uncontrolled systemic vasodilation, relative hypovolemia, profound hypotension, and characteristically inappropriate bradycardia.
    • Clinical Management: Supportive stabilization focused on airway security, fluid resuscitation, vasopressor support to restore systemic vascular resistance, and targeted neurological protection.

Obstructive Shock and Critical Nursing Resuscitation Priorities

  • Pathophysiology: Mechanical blockage that prevents flow through the cardiovascular circuit external to the myocardium itself.

  • Etiological Causes:

    • Pericardial tamponade: Accumulation of fluid within the pericardial sac that compresses the heart and limits ventricular filling.
    • Tension pneumothorax: Unilateral thoracic pressure shifts mediastinal structures, kinking and compressing the great vessels.
    • Intrathoracic mediastinal neoplasms.
    • Massive pulmonary embolism (PE) obstructing right ventricular outflow.

  • Clinical Management:

    • Immediate relief of physical obstruction (e.g., emergent pericardiocentesis for tamponade; needle chest decompression followed by thoracostomy tube placement for pneumothorax; embolectomy or thrombolysis for pulmonary embolism).
    • Application of high-concentration supplemental oxygen.
    • Elevation of the head of the bed to optimize respiratory mechanics.

  • Critical Nursing Resuscitation Priorities:

    • Anxiety and Pain Management: Uncontrolled severe pain and psychological anxiety dramatically elevate systemic metabolic stress, myocardial workload, and systemic oxygen consumption.
    • Shivering Prevention: Involuntary muscle shivering significantly accelerates cellular oxygen consumption and rapidly depletes reserves. Immediate steps must be taken to prevent and halt shivering.
    • Thermoregulation During Transfusion:
      • Whole blood and component blood products are stored refrigerated in blood bank facilities.
      • Rapid infusion of cold intravenous blood products induces hypothermia, which triggers severe shivering and metabolic decompensation.
      • Active inline blood warmers must be utilized during rapid fluid and blood product administration to maintain normothermia and minimize cellular oxygen consumption.